Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
First published online on May 19, 2008
Chest, doi:10.1378/chest.07-2626
A more recent version of this article appeared on September 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
chest.07-2626v1
chest.07-2626v2
134/3/483    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Makris, D.
Right arrow Articles by Gourgoulianis, K. I.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Makris, D.
Right arrow Articles by Gourgoulianis, K. I.

Tc2 response at the onset of COPD exacerbations

Demosthenes Makris1; Stelios Lazarou1; Michael Alexandrakis2; Taxiarchis V. Kourelis2; Nikos Tzanakis3; Despina Kyriakou4 and Kostas I. Gourgoulianis1

1Department of Thoracic Medicine, University Hospital, Medical School, University of Larisa, Larisa, Greece 2Department of Hematology, University Hospital, Medical School, University of Crete, Heraklion, Greece 3Department of Epidemiology, Medical School, University of Crete, Heraklion, Greece 4Department of Hematology, University Hospital, Medical School, University of Larisa, Larisa, Greece

appollon7{at}med.uth.gr

Abstract

BackgroundT lymphocytes and especially the subpopulations of CD8 positive cells (CD8+) are believed to have a key role in COPD pathophysiology but there is only few data regarding the role of these cells in COPD exacerbation.

AimWe aimed to study prospectively changes of CD8+ T-lymphocyte subpopulations in the sputum of COPD patients, at the onset of mild exacerbations and at a stable condition in order to provide further insight in the pathophysiology of the disease.

MethodsInduced sputum samples were collected from 24 COPD patients with median (IQR) 52 (44-58) years and FEV1%pred 78.05 (75.8-80.1) at the onset of mild exacerbations not requiring hospitalization and when stable. Inflammatory cells and T-lymphocyte subpopulations (CD4+, CD8+ and cells producing IFN-{gamma}, or IL-4) were measured using flow cytometry and immunocytochemical methods.

ResultsA significant increase in sputum CD8+ T-lymphocytes (p<0.0001) and significant decreases in CD4+ T-lymphocytes as well as in CD4+/CD8+ (p=0.0001) and CD8+IFN{gamma}+/CD8+IL4+, CD4+IFN{gamma}+/CD4+IL4+ (p=0.0001) sputum cells ratios were found decreased at the onset of exacerbations compared to stable condition. The changes in T-lymphocyte subpopulations were not associated with smoking history, demographic characteristics or disease severity.

ConclusionThe findings of the present study suggest that CD8+ lymphocytes are increased and potentially polarized towards a Tc2 profile in the airways of COPD patients at the onset of COPD exacerbations in respect to stable condition. The clinical impact of the observed phenomenon requires further investigation.

Key Words: COPD • lymphocytes • exacerbations







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the American College of Chest Physicians.